Parkwood LLC’s Acadia Pharmaceuticals ACAD Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-50,749	Closed	-$825K	–	87
2024 Q2	$825K	Buy	50,749 +4,479	+10%	+$72.3K	0.1%	97
2024 Q1	$856K	Buy	46,270 +23,806	+106%	+$590K	0.09%	149
2023 Q4	$703K	Buy	22,464 +2,116	+10%	+$50.5K	0.11%	98
2023 Q3	$424K	Buy	20,348 +1,813	+10%	+$49.2K	0.08%	104
2023 Q2	$444K	Buy	18,535 +1,393	+8%	+$31K	0.08%	107
2023 Q1	$323K	Sell	17,142 -10,174	-37%	-$194K	0.06%	130
2022 Q4	$435K	Buy	27,316 +8,915	+48%	+$139K	0.09%	113
2022 Q3	$301K	Sell	18,401 -6,433	-26%	-$104K	0.06%	129
2022 Q2	$350K	Buy	24,834 +7,762	+45%	+$145K	0.07%	124
2022 Q1	$413K	Sell	17,072 -3,976	-19%	-$96.2K	0.07%	104
2021 Q4	$491K	Sell	21,048 -7,505	-26%	-$151K	0.09%	94
2021 Q3	$474K	Buy	28,553 +5,136	+22%	+$99K	0.08%	102
2021 Q2	$571K	Sell	23,417 -3,039	-11%	-$68.6K	0.1%	107
2021 Q1	$683K	Buy	26,456 +988	+4%	+$43.5K	0.12%	84
2020 Q4	$1.36M	Buy	+25,468	New	+$1.26M	0.23%	84